🇮🇳

Index Intelligence

· daily

BSE Realty Real Estate Sector Regulatory Filings — October 27, 2026

Only one filing is in the stream, Godrej Properties' Q2 FY27 analyst/investor meet disclosure, so portfolio-level comparisons are not possible and conclusions rest on a single company. Booking value fell 6% YoY and 7% QoQ to INR8,008 crore in Q2, though H1 bookings rose 7% YoY to INR16,669 crore, indicating a soft quarter within a stronger half-year. Sustenance sales surged 83% YoY and collections rose 31% YoY, showing cash generation strength from the existing project pipeline. Reported profitability deteriorated sharply: total income grew 38% to INR2,575 crore while EBITDA fell 72% to INR171 crore and net profit fell 62% to INR154 crore, reflecting back-ended project delivery and recognized consolidation losses. Management is guiding to a record H2 for launches and sales, INR15,000 crore of cash collections and INR7,000 crore of operating cash flow, and positive free cash flow with a 20% reported ROE in FY28. The key market question is whether the H2 launch and collection targets materialize to offset the sharp margin compression in the current period.

1 medium 1 total filings
· daily

BSE IT Technology Sector Regulatory Filings — October 27, 2026

The Q2 FY27 (quarter ended September 30, 2026) filings from India's S&P BSE IT constituents are dominated by NIIT Limited, which accounts for six of the ten filings and shows a clearly weakening top line: revenue from operations fell about 6% YoY to Rs. 982.17 Mn, total income fell about 10% YoY to Rs. 1,066.84 Mn, and the company swung to a consolidated loss after tax attributable to owners of Rs. 21.88 Mn from a profit of Rs. 13.73 Mn a year earlier. Partial offsets include a sequential revenue uptick of about 3% QoQ, EBITDA turning positive at Rs. 27 Mn versus negative Rs. 14 Mn in Q1, and order intake rising 36% QoQ, though order intake and technology programs were both down YoY (-11% and -13%). Profitability pressure is compounded by depreciation up 43% YoY to Rs. 103 Mn (largely tied to the iamneo acquisition) and treasury income falling to Rs. 41 Mn from Rs. 85 Mn a year earlier. Leadership transition (Anish Sarkar as CEO from October 14, 2026) and a Chief Growth Officer appointment signal a strategic reset toward acquisition-led growth. Among the larger names, Infosys, LTM and KPIT produced only operational or governance disclosures without financial figures, while LTM's up-to-USD 100 Mn two-year banking engagement is the most material positive development in the set. Coforge's filing is a CSR item and Happiest Minds only schedules an earnings call, so portfolio-level financial read-through is limited to NIIT's deterioration.

2 high priority 8 medium 10 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — October 27, 2026

Across the 18 filings for the BSE SENSEX 30 stream dated 2026-10-27, the dominant theme is a sharp divergence between top-line strength and profitability. Maruti Suzuki reported record Q2 volumes (+26.5% YoY to 696,654 units) and net sales up 26%, yet PAT fell 26.9% YoY to INR 24,149 million as material costs rose to 79.9% of net sales from 75.7%, with West Asia-linked commodity inflation, adverse FX and mark-to-market losses on surplus investments compressing margins. Larsen & Toubro showed a similar pattern: revenue up 16% and PAT up 33% YoY, but consolidated EBITDA margin contracted to 8.7% from 10.0%, with a record Q2 order inflow of INR 1,477 bn and an order book of INR 8,535 bn offering medium-term visibility. UltraTech Cement grew net profit 21% and volumes 13.8% with capacity utilization rising to 71% from 66%, but flagged fuel cost inflation of roughly 13% QoQ and expects that headwind into H2, with price recovery benefits expected in Q3. Governance and leadership events were concentrated at HDFC Bank, where CEO Sashidhar Jagdishan completed his tenure and Anup Bagchi took over effective October 27. Several filings (Reliance, Bharat Electronics, the Maruti call-recording notice) were procedural and carry no financial data, so near-term catalysts are the Reliance results on October 30 and the BEL call on November 3. Overall, the market implication is that cost pass-through and margin recovery, not volume growth, will determine earnings direction in the next two quarters.

6 high priority 12 medium 18 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — October 26, 2026

Six filings were reviewed for the India BSE BANKEX stream covering 26 October 2026. None of the filings carries period-over-period financial figures, insider trading data, guidance, capital allocation or transaction terms; each is a procedural or informational disclosure (ESOP allotment, results-meeting schedules, earnings-call transcript posting, ESG rating). The most material development is the convergence of Q2 FY27 results cycles: State Bank of India's Central Board meets on 3 November 2026 with an analyst meet the same day, and Bank of Baroda holds its media and analyst meets on 30 October 2026, so the near-term catalyst calendar is dense. Axis Bank's transcript posting confirms its 17 October Q2 FY27 earnings call content is public, but the filing itself does not reproduce any metrics, so no quantitative trend can be drawn. Kotak Mahindra Bank's independent ESG score of 70 for FY2025-26 is the only third-party quantitative signal in the batch. Because the enriched fields are empty for these filings, conclusions are limited to event timing, trading-window status and disclosure hygiene, and investors should defer directional views until the 30 October and 3 November results are published.

6 medium 6 total filings
· daily

BSE Metal Sector Regulatory Filings — October 26, 2026

The BSE METAL stream for 26 October 2026 is dominated by a single company, APL Apollo Tubes, which filed five of the eight items around its Q2 FY27 results. Headline growth was strong: consolidated Q2 revenue rose 26.6% to ₹7,001.70 Cr (34% YoY per the investor presentation, on a different base), PAT rose 26.8% to ₹382.42 Cr, and H1 revenue reached ₹12,608.41 Cr (up 17.8% in the filing's own comparison, 22% in the presentation). Quality of growth is the central debate: H1 volumes grew only 4% YoY against 22% revenue growth, implying price/mix rather than volume drove the top line, and Q2 EBITDA per ton rose just 9% QoQ. Balance-sheet signals turned more cautious, with debt rising to ₹9,181 Mn from ₹4,525 Mn at FY26 end, interest cost up 90% YoY in Q2, H1 free cash flow falling to ₹1,795 Mn from ₹13,364 Mn for all of FY26, and a ₹1,55,000 (likely ₹1,550 Cr) related-party acquisition of a further 31% in SG Enterprise Solutions expected to close by 31 December 2026. Lloyds Metals and Energy's two postal-ballot resolutions passed comfortably, but roughly half of public institutional votes opposed the independent director appointment, a governance signal worth monitoring. Overall sentiment is mixed: operating momentum is strong while cash conversion, leverage and the quality of volume growth need validation.

3 high priority 5 medium 8 total filings
· daily

BSE Auto Sector Regulatory Filings — October 26, 2026

Across the ten BSE AUTO-stream filings dated 26 October 2026, the dominant story is Sona BLW Precision Forgings, which reported a strong Q2 FY27 with revenue up 35% YoY to ₹15,464 mn, PAT up 29% YoY, and H1 FY27 revenue up 43%, but with EBITDA margin compressing about 2.3 points to 23.0% and PAT margin about 0.5 points lower at 14.4%, signalling that top-line momentum is outpacing cost absorption. Its net order book of ₹251 bn (5.6x FY26 revenue) is heavily weighted to EV programs (61%), and the company is now in a net cash position, a balance sheet strength that supports its growth pipeline. Sona's record quarter is the clearest quantitative datapoint in the stream, and it is the one most relevant to portfolio decisions. The remaining filings are largely procedural: UNO Minda, Bosch and Tube Investments have scheduled results board meetings and analyst calls for 5–6 November 2026 with trading windows closed, so the period-over-period picture for those names is not yet visible. Samvardhana Motherson received NCLT approval for a demerger and amalgamation scheme effective from an April 2024 appointed date, a structural event with limited near-term P&L impact but meaningful for group simplification. Hyundai Motor India's BAYON launch at ₹9,99,900 ex-showroom and planned exports to 50+ markets is the only product-cycle catalyst in the set. Overall, the stream points to a sector in growth-led expansion, with EV-linked order wins driving the outlook, while margin pressure from scaling is the principal watch item.

2 high priority 8 medium 10 total filings
· daily

BSE FMCG Sector Regulatory Filings — October 26, 2026

Seven filings from the S&P BSE FMCG constituent set were reviewed for 26 October 2026, covering Tata Consumer Products (five filings), Dabur India and Emami. Tata Consumer's Q2 FY27 headline numbers were strong at the consolidated level: revenue from operations rose 14% YoY to Rs 5,661 Cr, consolidated EBITDA grew 18% to Rs 794 Cr with margins up 40 bps to 14.0%, and group net profit rose 16% to Rs 470 Cr. Beneath the headline, growth was uneven: India Branded business grew 17% (11% underlying volume growth), while International revenue grew only 7% (-2% in constant currency), UK revenue fell 8% in constant currency on the heatwave, and Non-branded Plantations fell 11% as Arabica and Robusta prices softened. Standalone PAT fell about 15% YoY to Rs 243 Cr despite 17% revenue growth because of Rs 64 Cr of exceptional items (a Rs 57 Cr fair value loss on an associate's financial instrument and a Rs 7 Cr contingent consideration adjustment), so the standalone earnings quality question is the key item to track. Senior management changes at Tata Consumer are routine and low-materiality, while Dabur and Emami filings are purely procedural investor-meet and call intimations with no Q2 financial figures disclosed, so the near-term catalyst set centres on the 5 November 2026 Dabur and Emami events.

2 high priority 5 medium 7 total filings
· daily

BSE Pharma Sector Regulatory Filings — October 26, 2026

Across the 15 BSE Pharma constituent filings dated 2026-10-26, the dominant theme is an active earnings cycle: Mankind Pharma (the most heavily represented name with 8 filings) reported strong consolidated growth, with revenue up 17.3% YoY to INR 4,338 Cr, EBITDA up 27.2% to INR 1,175 Cr, and PAT up 37.7% to INR 716 Cr, while standalone revenue rose about 19% YoY to INR 3,145 Cr. The growth is not uniform: Consumer Healthcare grew only 1.2% YoY and fell 7.0% QoQ, and consolidated employee costs and standalone other expenses grew faster than revenue, which tempers the margin story. Standalone finance costs fell sharply to INR 87.74 Cr from INR 149.22 Cr and total standalone borrowings declined from about INR 5,488 Cr to about INR 4,490 Cr in six months, signalling deleveraging. Peers Aurobindo, Abbott India, Pfizer, and Biocon have all announced Q2 FY27 board meetings clustered between November 3 and 5, 2026, with trading windows closed, so the main quantitative catalysts for the group fall in the next two weeks. Biocon's Yesintek licence expansion and Sun Pharma's INR 7,816 Cr NCD placement are the notable non-results developments. Mankind's pending amalgamations and the unresolved Section 132 income-tax dispute are the principal structural items to monitor.

4 high priority 11 medium 15 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — October 26, 2026

The eight filings span the S&P BSE REALTY constituent set, but the substantive financial content is concentrated almost entirely in Aditya Birla Real Estate Limited (ABREL), which generated five of the eight filings and dominates the period's signal. ABREL's headline Q2 FY27 numbers are inflated by a Rs 868.12 Cr exceptional gain from the sale of its Pulp and Paper business to ITC for Rs 3,476 Cr, producing consolidated net profit of Rs 918.70 Cr; underlying operations are mixed, with continuing-operations sales rising sharply off a very low base (Rs 824.27 Cr vs Rs 96.77 Cr) while standalone Real Estate segment revenue fell 7.7% YoY for the half-year and booking value declined 67% YoY in Q2 (Rs 298 Cr). Balance-sheet repair is the most constructive element: standalone debt-to-equity fell to 0.37x from 0.89x and consolidated net worth rose to Rs 4,622.72 Cr from Rs 3,797.24 Cr, though consolidated current liabilities remain elevated at Rs 11,362.27 Cr and the six-month standalone DSCR is only 0.03x. CARE's outlook revision on BEPL to AA Positive is a credit-quality positive. Godrej Properties, Phoenix Mills and Brigade contributed operational or event-driven news (4,000+ Pune homes targeted by March 2027, Phoenix results on 30 October, two new Hyatt hotels adding 600 rooms in Bengaluru) but no quantified financials. Overall sentiment is mixed-to-cautiously-positive, with the market's attention best directed to ABREL's post-divestment capital structure and the upcoming Phoenix results.

2 high priority 6 medium 8 total filings
· daily

BSE IT Technology Sector Regulatory Filings — October 26, 2026

Six filings from S&P BSE IT constituents (HCL Technologies, Persistent Systems, L&T Technology Services, Coforge) were reviewed for the 2026-10-26 window. Three are newly published and three are carried over for context. The filings are dominated by business development and deal news rather than financial results, so period-over-period comparisons (YoY/QoQ revenue, margin, and ratio trends) are not disclosed in any filing and cannot be quantified from this set. The most material development is Persistent Systems' closure of a Qualified Institutional Placement at INR 5,550 per share (7,683,981 shares), a 3.66% discount to the floor price, which signals a capital-raising event with dilution implications. On the demand side, the flow of engagements (LTTS's five-year Nokia engineering contract, HCLTech's Rapidus development centers, Coforge's Everest Group Leader positioning) points to continued momentum in AI-linked engineering and semiconductor services. HCLTech's completed Robotiq.ai acquisition is disclosed without value terms, limiting valuation assessment. Insider activity, forward guidance, and capital allocation data are absent from these filings, so conviction and shareholder-return signals must be treated as unavailable rather than neutral.

6 medium 6 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — October 26, 2026

Across the 11 filings dated 26 October 2026, the stream is dominated by procedural and event-driven disclosures rather than hard financial results: four of the eleven filings (State Bank of India board/analyst notices, Bharti Airtel's board notice, UltraTech's corporate dossier, Axis Bank's earnings-call transcript) reference upcoming or past results but disclose no period-over-period figures, so no reliable YoY or QoQ trend can be drawn from this batch. The most material development is Sun Pharmaceutical's completion of INR 7,816 crore of rated unsecured NCDs (base INR 7,000 crore fully subscribed plus INR 816 crore greenshoe), priced at 8.05% (Series A) and 8.20% (Series B), signalling strong institutional demand for a large-cap pharma credit at a high-single-digit coupon. HCL Technologies dominated the corporate-news flow with three filings (Robotiq.ai acquisition closure, Rapidus development centres, Climate Action Grant expansion), which together point to continued bolt-on M&A and deepening semiconductor engineering exposure, though no deal value or headcount was disclosed. Calendar-wise, the cluster is front-loaded around the 3-5 November 2026 window, when SBI (3 Nov), Bharti Airtel (5 Nov) and Bajaj Finance's analyst meet (5 Nov) are scheduled, making this the key period for portfolio-level read-through once results land. Kotak's independently assigned NSE ESG rating of 70 for FY2025-26 and UltraTech's sector demand outlook (7-8% CAGR to FY30) add background sustainability and structural-growth context rather than near-term catalysts.

11 medium 11 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — October 25, 2026

This stream covers a single filing from IDFC First Bank Limited (a S&P BSE BANKEX constituent) dated 2026-10-25, which is an intimation under Regulation 30 confirming that the audio recording of the October 24, 2026 analyst/investor earnings call on Q2 FY27 unaudited results has been posted to the Bank's website. The filing is procedural in nature and contains no financial figures, so no period-over-period revenue, margin, NIM, or asset-quality comparisons can be drawn from it. No insider trading, pledge, capital allocation, M&A, or forward-looking guidance data is disclosed in the filing. Sentiment is neutral with low materiality (2/10). Portfolio-level trends cannot be established from a single procedural filing; the practical implication is that investors should obtain the actual Q2 FY27 results and call transcript content directly from the recording or the Bank's results release to assess performance. The notable item is simply that the call took place and the replay is available.

1 medium 1 total filings
· daily

BSE IT Technology Sector Regulatory Filings — October 25, 2026

The stream contains a single filing from L&T Technology Services Limited (LTTS), an in-scope S&P BSE IT constituent, reporting Q2 FY27 results with revenue of ₹3,040 crore, up 3.4% QoQ and 12.1% YoY. EBIT margin expanded to 16.3% (up 60 bps QoQ and 220 bps YoY), a clear period-over-period operating improvement. Headline net income of ₹548 crore (up 53.7% QoQ and 66.8% YoY) is flattered by a one-time ₹165 crore gain from the SWC divestment, so underlying earnings growth is materially lower than the reported figures suggest. Order momentum was strong, with large-deal TCV of $203 million (over 50% AI-led) and an annualized EI-led revenue run-rate of $120 million, though Auto Europe remained muted, Tech was described as stable, and a Medtech program is ramping down. Management guided to a ₹20 per share interim dividend and flagged a 50-80 bps margin headwind from a Q3 wage hike, so the near-term margin trajectory hinges on AI-led deal conversion. With DSO at 78 days (billed 60, unbilled 18) inside the guided 80-85 day range, working capital discipline appears intact. The overall read is constructive on fundamentals but mixed on quality of earnings and near-term margin direction.

1 medium 1 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — October 24, 2026

Across the 19 filings for the BSE BANKEX stream (all dated 24 Oct 2026), Q2 FY27 results from Kotak Mahindra Bank, AU Small Finance Bank and IDFC FIRST Bank show strong headline profit growth year-on-year, but sequential momentum is flat-to-mixed and margins and deposit mix are under pressure. Kotak standalone PAT rose 29.5% YoY to Rs 4,212 cr but only 2% QoQ, with NIM compressing to 4.31% from 4.54% and CASA falling to 38.2% from 42.3%, largely on FCNR(B) mobilisation. AU SFB delivered PAT up 52.9% YoY to Rs 858 cr and 7.7% QoQ, with deposits up 29% and loans up 25%, though yield on advances fell 9 bps QoQ and LCR eased to 116%. IDFC FIRST reported PAT of Rs 1,045 cr (up 196.5% YoY) but down 2.8% QoQ, CASA falling 167 bps QoQ to 48.4%, and CAR slipping to 14.67% from 15.05%. The common theme is that FCNR(B) deposit mobilisation under the RBI window is flattering growth and diluting CASA and NIM across peers. The most critical item is Yes Bank's unresolved AT-1 coupon decision following the Supreme Court judgment, which is a clear negative for bondholders and sector sentiment. Management leadership transitions at Kotak (new MD & CEO from 1 Jan 2027) and IDFC FIRST (new Chairperson from May 2027) are governance events to monitor.

7 high priority 12 medium 19 total filings
· daily

BSE Metal Sector Regulatory Filings — October 24, 2026

This BSE METAL stream digest covers three filings dated 2026-10-24, but only one company in the stream's scope is clearly represented: Tata Steel Limited, which is a S&P BSE METAL constituent. The two Adani Enterprises Limited filings concern postal ballot results approving the appointment of Ms. Anju Abrol as an Independent Director, which passed with 99.96% of votes in favour and 91.01% of paid-up capital participating. Those filings are governance-routine and carry low materiality (3/10 and 4/10), with no period-over-period financials, insider transactions, capital allocation changes, or forward guidance in the supplied enrichment. Tata Steel's filing is a corporate governance notice postponing its Q2/H1 FY results board meeting from October 27 to November 7, 2026, with the trading window closed since September 24, 2026 and reopening 48 hours after results. The postponement is the key time-sensitive item: no quarterly metrics are available yet, so the market will be waiting on results rather than acting on them. Enriched period comparisons, insider activity, and guidance are absent across all three filings, so this digest cannot support quantitative trend analysis and should be read as a calendar and governance update.

3 medium 3 total filings
· daily

BSE Auto Sector Regulatory Filings — October 24, 2026

This stream covers a single filing from Maruti Suzuki India Limited, a constituent of the S&P BSE AUTO index, and it is a non-financial press release announcing the VICTORIS AURUM Edition Strong Hybrid to mark the VICTORIS SUV's first anniversary. The filing discloses no financial results, so no period-over-period comparison of company performance, margins, or guidance is available from the enriched data, and no insider transactions, capital allocation actions, or forward-looking financial targets were reported. The main development is commercial momentum in the VICTORIS model, which the company says set a record for first-year sales of a new passenger vehicle launch and became the fastest to cross the 1 lakh and 1.5 lakh sales milestones in India. Award recognition (ICOTY 2026 and multiple Car of the Year titles) and a low-cost variant launch at a INR 22,990 kit price point suggest sustained demand and product-led share defence in the mid-SUV segment. Market implications are positive but modest: the filing supports the demand thesis for Maruti's SUV portfolio, yet materiality is low (3/10) because it contains no quantified earnings impact.

1 medium 1 total filings
· daily

BSE FMCG Sector Regulatory Filings — October 24, 2026

Both filings in this stream relate to Emami Limited (NSE: EMAMILTD, BSE: 531162), an S&P BSE FMCG constituent, and they are substantively duplicative: each announces the same Board meeting on Thursday, 5th November 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended 30th September 2026 and to consider/declare an interim dividend for FY 2026-27, alongside a trading window closure running from 1st October 2026 until Saturday, 7th November 2026. The enriched period-over-period comparisons, forward-looking guidance, insider transaction, capital allocation, and financial ratio fields are not populated in the supplied filings, so no quantitative YoY or QoQ trends, margin data, or insider signals can be substantiated from this set. The primary market-relevant development is the upcoming quarterly results and interim dividend decision, which will provide the first hard data points for the period. Sentiment is neutral and materiality is moderate (5/10), consistent with a routine governance and results-calendar notice rather than a stock-moving event. The trading window closure is standard pre-results practice and signals that insiders are restricted from dealing until after the announcement.

1 high priority 1 medium 2 total filings
· daily

BSE Pharma Sector Regulatory Filings — October 24, 2026

Three filings dated October 24, 2026 were reviewed for the India BSE PHARMA stream, and all three are administrative or event-notice disclosures rather than financial results. Dr. Reddy's published links to its October 23 Q2 FY27 earnings call recordings, which carry no figures in the filing itself, so any period-over-period or margin analysis must be sourced from the recordings or the results release. Zydus Lifesciences scheduled its Q2 FY27 results declaration and post-results call for November 4, 2026 at 3:30 p.m. IST, creating the only dated catalyst in this batch. Lupin disclosed a closed U.S. FDA inspection of its Goa facility (October 19-23, 2026) with one Form-483 observation, which is the most material item at 5/10 but is unquantified and lacks detail on the observation's nature. Because the enriched fields for period comparisons, insider activity, guidance, capital allocation and valuation are absent from these filings, no quantitative cross-company trend, outlier or insider-pattern conclusions can be drawn today. The key portfolio-level takeaway is regulatory and disclosure-driven news flow rather than fundamental change, with the Zydus call and the Lupin 483 response as the items to track.

3 medium 3 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — October 24, 2026

This digest covers a single filing from the S&P BSE REALTY constituent universe for the 2026-10-24 window: Sobha Limited's Final Reminder-cum-Forfeiture Notice for unpaid First and Final Call money on partly paid-up equity shares. The filing is a procedural Regulation 30 SEBI LODR disclosure with no financial performance data, so no period-over-period revenue, margin, or ratio trends are available for synthesis. The call amount of ₹25.50 per partly paid share (₹5.00 face value plus ₹20.50 premium) carries a payment window from November 10 to November 24, 2026, after which unpaid shares may be forfeited. Portfolio-level implications are limited: the event is a housekeeping capital-call enforcement step rather than a signal on operating health, and no insider transactions, guidance changes, dividends, buybacks, or M&A activity are disclosed. Investors should treat this as a low-materiality item (3/10) and monitor only for the outcome of the call window and any subsequent forfeiture or cash-raise disclosure.

1 high priority 1 total filings
· daily

BSE IT Technology Sector Regulatory Filings — October 24, 2026

Two filings from the S&P BSE IT constituent set were received for the 2026-10-24 window, and both are procedural in nature: an earnings call scheduling notice from Hexaware Technologies and a transcript link from Coforge Limited covering its Q2 FY27 call. Neither filing contains financial figures, period-over-period comparisons, insider transactions, capital allocation actions, or forward-looking guidance in the text supplied, so no quantitative trend synthesis across the pair is possible from the enriched data. The dominant developments are the timing of upcoming results communication and the availability of call materials for investors. Market implications are limited to event-calendar awareness rather than fundamental re-rating. The most actionable items are the Hexaware Q3 CY 2026 call on October 29, 2026 and the Coforge transcript, which should be reviewed for the substantive guidance and margin commentary that the filings themselves omit.

2 medium 2 total filings